Cargando…

Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237785/
https://www.ncbi.nlm.nih.gov/pubmed/35785046
http://dx.doi.org/10.1093/immadv/ltac013
_version_ 1784736878255144960
collection PubMed
description
format Online
Article
Text
id pubmed-9237785
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92377852022-06-29 Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes Immunother Adv Correction Oxford University Press 2022-06-22 /pmc/articles/PMC9237785/ /pubmed/35785046 http://dx.doi.org/10.1093/immadv/ltac013 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology.© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction
Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
title Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
title_full Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
title_fullStr Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
title_full_unstemmed Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
title_short Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
title_sort correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237785/
https://www.ncbi.nlm.nih.gov/pubmed/35785046
http://dx.doi.org/10.1093/immadv/ltac013